Rx Pricing Practices Are “Risk Factor” In Medicare Bill, Senate Staffer Says

The pharmaceutical industry's pricing practices are one "risk factor" that could jeopardize the Medicare prescription drug legislation, a staffer for Senate Finance Committee Ranking Member Max Baucus (D-Mont.) told a Dec. 9 Institute for International Research conference in Washington, D.C